{"url":"https://lda.senate.gov/api/v1/filings/332fcb02-e25c-4ce2-8a1b-e16f92d8e4a6/","filing_uuid":"332fcb02-e25c-4ce2-8a1b-e16f92d8e4a6","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/332fcb02-e25c-4ce2-8a1b-e16f92d8e4a6/print/","filing_document_content_type":"text/html","income":"60000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Beth Anne Cole","dt_posted":"2026-04-17T10:26:48-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"2231 48th Street NW","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20007","registrant":{"id":401108183,"url":"https://lda.senate.gov/api/v1/registrants/401108183/","house_registrant_id":56368,"name":"LMH STRATEGIC SOLUTIONS","description":null,"address_1":"2231 48th Street NW","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20007","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ALANNA TEMME","contact_telephone":"+1 202-503-5189","dt_updated":"2026-07-09T12:14:41.865548-04:00"},"client":{"id":63503,"url":"https://lda.senate.gov/api/v1/clients/63503/","client_id":63503,"name":"ALKERMES, INC.","general_description":"Biopharmaceutical company","client_government_entity":null,"client_self_select":false,"state":"MA","state_display":"Massachusetts","country":"US","country_display":"United States of America","ppb_state":"MA","ppb_state_display":"Massachusetts","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2025-01-01"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Medicare/Medicaid issues. Medicaid drug rebate program. Prescription drug pricing, including MDRP Substance Use Disorder Policy. Implementation of Inflation Reduction Act of 2022. H.R.946: ORPHAN Cures Act. Provide strategic counsel and advocate on issues related to the biopharmaceutical industry generally, and Alkermes, Inc. specifically. Provide guidance and advice regarding mental health, public health and regulatory reform.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":145804,"prefix":null,"prefix_display":null,"first_name":"ALANNA","nickname":null,"middle_name":null,"last_name":"TEMME","suffix":null,"suffix_display":null},"covered_position":"Legislative Director, U.S. Representative Jon Porter","new":false},{"lobbyist":{"id":153409,"prefix":null,"prefix_display":null,"first_name":"SOPHIE","nickname":null,"middle_name":null,"last_name":"KHANAHMADI","suffix":null,"suffix_display":null},"covered_position":"Legislative Asst., Rep. Martha Roby; Legislative Asst., Rep. Lee Terry; Staff Asst./LC, Senator Jeff Sessions","new":false},{"lobbyist":{"id":153410,"prefix":null,"prefix_display":null,"first_name":"MAXIMILIAN","nickname":null,"middle_name":null,"last_name":"WALTER","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":11,"name":"Executive Office of the President (EOP)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}